Seneca Biopharm Inc (SNCA) Stock Price, Quote, News and Overview
NASDAQ:SNCA - Nasdaq -
SNCA Quote, Performance and Key Statistics
1.66
-0.02 (-1.19%)
The current stock price of SNCA is 1.66 null. In the past month the price increased by 11.41%. In the past year, price increased by 140.58%.
About SNCA
Company Profile
Seneca Biopharma Inc. is a clinical-stage biopharmaceutical company. It focuses on developing novel treatments for diseases of unmet medical need. Seneca Biopharma Inc., formerly known as Neuralstem Inc, is based in GERMANTOWN, Md.
Company Info
Seneca Biopharm Inc
20271 Goldenrod Lane
Germantown MD 20876
CEO: Kenneth Carter
Phone: 301-366-4841
Seneca Biopharm Inc / SNCA FAQ
What is the stock price of Seneca Biopharm Inc today?
The current stock price of SNCA is 1.66 null. The price decreased by -1.19% in the last trading session.
What is the ticker symbol for Seneca Biopharm Inc stock?
The exchange symbol of Seneca Biopharm Inc is SNCA and it is listed on the Nasdaq exchange.
On which exchange is SNCA stock listed?
SNCA stock is listed on the Nasdaq exchange.
What is Seneca Biopharm Inc worth?
Seneca Biopharm Inc (SNCA) has a market capitalization of 28.71M null. This makes SNCA a Nano Cap stock.
What are the support and resistance levels for Seneca Biopharm Inc (SNCA) stock?
Seneca Biopharm Inc (SNCA) has a support level at 1.46 and a resistance level at 1.69. Check the full technical report for a detailed analysis of SNCA support and resistance levels.
Should I buy Seneca Biopharm Inc (SNCA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of SNCA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of SNCA, evaluating the profitability, health, valuation and growth aspects
- Seneca Biopharm Inc (SNCA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Seneca Biopharm Inc (SNCA) Sales and EPS estimates to see what analysts future expectations are.
- Seneca Biopharm Inc (SNCA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Seneca Biopharm Inc (SNCA) Insider and Institutional Ownership to learn about the owners and their transactions.
- Seneca Biopharm Inc (SNCA) Stock Chart to make your own analysis
- Seneca Biopharm Inc (SNCA) Latest news and press-releases to stay up to date.
Does Seneca Biopharm Inc (SNCA) stock pay dividends?
SNCA does not pay a dividend.
What is the Price/Earnings (PE) ratio of Seneca Biopharm Inc (SNCA)?
Seneca Biopharm Inc (SNCA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.17).
SNCA Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to SNCA. When comparing the yearly performance of all stocks, SNCA is one of the better performing stocks in the market, outperforming 86.73% of all stocks.
SNCA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SNCA. SNCA has a bad profitability rating. Also its financial health evaluation is rather negative.
SNCA Financial Highlights
Over the last trailing twelve months SNCA reported a non-GAAP Earnings per Share(EPS) of -1.17. The EPS increased by 69.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -120494.81% | ||
| ROA | -124.66% | ||
| ROE | N/A | ||
| Debt/Equity | 0.01 |